- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6769
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator ; volume:6 ; number:1 ; day:08 ; month:2 ; year:2006 ; pages:1-11 ; date:12.2006
BMC chemical biology ; 6, Heft 1 (08.2.2006), 1-11, 12.2006
- Creator
-
Heynekamp, Justin J.
Hunsaker, Lucy A.
Vander Jagt, Thomas A.
Deck, Lorraine M.
Vander Jagt, David L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1472-6769-6-1
- URN
-
urn:nbn:de:101:1-2021082520385423146447
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heynekamp, Justin J.
- Hunsaker, Lucy A.
- Vander Jagt, Thomas A.
- Deck, Lorraine M.
- Vander Jagt, David L.
- SpringerLink (Online service)
Other Objects (12)
Urokinase-type plasminogen activator receptor in vascular calcification
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor
In silico docking of urokinase plasminogen activator and integrins
Einfluss von Biopsie-, Aufarbeitungs- und Asservierungsbedingungen auf den Nachweis von urokinase type plasminogen activator (uPA) und plasminogen activator inhibitor-1 (PAI-1) beim Mammakarzinom
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer
Urokinase-type plasminogen activator receptor in vascular calcification
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor
In silico docking of urokinase plasminogen activator and integrins
Einfluss von Biopsie-, Aufarbeitungs- und Asservierungsbedingungen auf den Nachweis von urokinase type plasminogen activator (uPA) und plasminogen activator inhibitor-1 (PAI-1) beim Mammakarzinom
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer
Urokinase-type plasminogen activator receptor in vascular calcification
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor
In silico docking of urokinase plasminogen activator and integrins
Einfluss von Biopsie-, Aufarbeitungs- und Asservierungsbedingungen auf den Nachweis von urokinase type plasminogen activator (uPA) und plasminogen activator inhibitor-1 (PAI-1) beim Mammakarzinom